E0 ConsensusModerate confidencePEM not requiredSystematic-ReviewPeer-reviewedMachine draft
Standard · 3 min
The prevalence of fibromyalgia in other chronic pain conditions.
Yunus, Muhammad B · Pain research and treatment · 2012 · DOI
Quick Summary
This review examined how often fibromyalgia (a condition causing widespread pain and fatigue) occurs alongside other chronic pain conditions, including ME/CFS. The researchers found that fibromyalgia frequently co-occurs with conditions like rheumatoid arthritis, lupus, and osteoarthritis, and that it can be missed or misdiagnosed in people who have these other diseases. Recognizing fibromyalgia separately is important because it may change how doctors treat patients and what medications they use.
Why It Matters
For ME/CFS patients, this study confirms that multiple pain-related conditions often occur together and share common underlying mechanisms (central sensitization). It highlights the clinical importance of recognizing fibromyalgia as a distinct problem even when other diagnoses are present, which could improve treatment decisions and reduce unnecessary medications. Understanding these overlapping syndromes helps validate patient experiences and guides more targeted management strategies.
Observed Findings
Fibromyalgia syndrome is highly prevalent among other central sensitivity syndromes, including ME/CFS, IBS, and restless legs syndrome.
Fibromyalgia frequently co-occurs with structural/inflammatory conditions such as rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, osteoarthritis, and inflammatory bowel disease.
Fibromyalgia can be present and clinically significant even when underlying inflammatory diseases (e.g., RA, SLE) are in remission or mild.
Missing or underdiagnosing fibromyalgia in patients with other chronic pain conditions may lead to inappropriate medication escalation, including unnecessary corticosteroid use.
Inferred Conclusions
Central sensitivity syndromes and structural pain conditions share overlapping pathophysiology and should be understood as mutually associated rather than competing diagnoses.
Clinicians must maintain high diagnostic suspicion for fibromyalgia in patients with other chronic pain conditions, particularly when symptoms persist despite treatment of the primary condition.
Separate recognition and diagnosis of fibromyalgia is essential to guide appropriate treatment and avoid iatrogenic harm from inappropriate medication use.
Remaining Questions
What are the specific prevalence rates of FMS in each CSS and structural pain condition, and how do these rates vary across different populations and healthcare settings?
What This Study Does Not Prove
This review does not establish causation—only that FMS and other CSS conditions frequently co-occur. It does not prove that central sensitization is the sole cause of these conditions, nor does it demonstrate whether one condition causes another or whether they share a common underlying mechanism. The review also cannot determine whether improved recognition and separate diagnosis of FMS actually leads to better patient outcomes.
Tags
Symptom:PainFatigue
Method Flag:PEM Not DefinedWeak Case DefinitionMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Does earlier or more accurate recognition of comorbid FMS in patients with RA, SLE, and other conditions improve long-term outcomes and quality of life?
What mechanisms explain why FMS frequently co-occurs with structurally distinct conditions—is central sensitization a primary driver, or are there other shared biological pathways?
How should treatment algorithms be modified when FMS is diagnosed alongside inflammatory or structural disease?